On Monday, as market get open in early hours a new high in share market reported. Let us share that  Natco Pharma new shares reported a high by 20 per cent to Rs 1,188.95. Here it is to be noted that  this shares is new high on the BSE in intra-day trade. As per trend following on market noted that this hike in share noted after  the company said it has received approval from the US health regulator for the generic version of Celgene’s multiple myeloma drug, Revlimid (Lenalidomide) capsules in US. Here it is needed to mention that this Lenalidomide capsule is used for treatment of adults with multiple myeloma, mantle cell lymphoma and myelodysplastic syndromes.

As per recent report from source media, it is to be noted that the stock has zoomed 30 per cent. At 09:48 am, Natco Pharma was trading 11 per cent higher at Rs 1,101 on the BSE, as compared to 0.24 per cent rise in the S&P BSE Sensex. With this surge in Natco shares the trading volumes on the counter jumped over five-fold with a combined 3.8 million equity shares. In a separate regulatory filing, Natco Pharma said that its marketing partner, Breckenridge Pharmaceutical Inc (BPI), has received final approval for its Abbreviated New Drug Application (ANDA) for Everolimus tablets (generic for Zortress), from the USFDA. BPI plans to launch 0.25mg, 0.5mg and 0.75mg strengths of the product shortly, which are indicated in the prophylaxis of organ rejection in kidney transplantation and liver transplantation, it said.

However, here it is to be noted that Natco also said the company has initiated Phase-III clinical trial of Molnupiravir capsules in India. Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2 replication. Patients treated with Molnupiravir achieved response within 5 days of therapy indicating that the duration of treatment with Molnupiravir is short, with the additional advantage of being an oral therapy.

Ace of Spades Digital PR Agency: What Does it Mean to be an Influencer?

Anand Srivastava- The new sensation in digital marketing industry!

Covid-19 impact: Retail sales hit hard; Health, hygiene, instant food products sales went up

What to watch out for markets this week, Major stocks in focus